Search

everythinglearnresearchcommunity

for

Search:↓

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Tofacitinib may help treat severe hair loss, but more research is needed.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Alefacept does not effectively treat severe alopecia areata.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Baricitinib works better than methotrexate for severe alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.